Chen, H.X.; Tsai, L.-H.; Chang, C.-H.; Wu, H.-C.; Lin, C.-C.; Lin, C.-H.; Yeh, C.-C.; Yang, C.-R.; Lien, C.-S.; Chang, Y.-H.;
et al. Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study. Cancers 2023, 15, 3516.
https://doi.org/10.3390/cancers15133516
AMA Style
Chen HX, Tsai L-H, Chang C-H, Wu H-C, Lin C-C, Lin C-H, Yeh C-C, Yang C-R, Lien C-S, Chang Y-H,
et al. Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study. Cancers. 2023; 15(13):3516.
https://doi.org/10.3390/cancers15133516
Chicago/Turabian Style
Chen, Hao Xiang, Li-Hsien Tsai, Chao-Hsiang Chang, Hsi-Chin Wu, Ching-Chan Lin, Che-Hung Lin, Chin-Chung Yeh, Chi-Rei Yang, Chi-Shun Lien, Yi-Huei Chang,
and et al. 2023. "Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study" Cancers 15, no. 13: 3516.
https://doi.org/10.3390/cancers15133516
APA Style
Chen, H. X., Tsai, L.-H., Chang, C.-H., Wu, H.-C., Lin, C.-C., Lin, C.-H., Yeh, C.-C., Yang, C.-R., Lien, C.-S., Chang, Y.-H., Liang, J.-A., Chen, G.-H., Hsiao, P.-J., Hsieh, P.-F., & Huang, C.-P.
(2023). Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study. Cancers, 15(13), 3516.
https://doi.org/10.3390/cancers15133516
